Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

QLO Capital joins the Trium Multi-Manager Alliance

Monday, October 14, 2013
Opalesque Industry Update, for New Managers - Trium Capital welcomed QLO Capital onto their multi-manager platform. The platform, Trium Multi-manager Alliance ("TMA"), launched late last year, is an innovative alliance of quantitative and systematic style early stage hedge fund managers. Managers that join TMA will be entering into an alliance with a range of like-minded outstanding hedge fund managers, sharing offices and central control function resources with each other, thus benefiting from significant economies of scale. TMA is structured so that early-stage managers meet the operational due diligence requirements required by institutional investors on day one.

QLO Capital is a global macro investment strategy that uses a systematic multi-strategy approach to investments, trading liquid futures across commodities, equities, fixed income and currencies. At its core are 13 quantitative strategies across both momentum and mean reversion. However a discretionary overlay is a core part of the value proposition.

QLO Capital has a positive live track record over the past 8 years, recently managing USD 450m for ATP in Denmark. The strategy was initiated by Lars Wind whilst working for ADIA, and Lars was joined by Betina Wolf-Andersen in 2008.

Gareth James, CEO of Trium Capital, said "We are delighted to welcome QLO Capital to our the TMA platform. Lars and Betina have a proven track record, and the discretionary overlay adds real appeal to investors."

Lars Wind, Chief Investment Officer of QLO Capital, said "This is a significant and strategic move for QLO. We had considered a number of options but found the value proposition offered by Gareth and his team compelling and by far the best solution.

Trium gives us the robust infrastructure and operational expertise that allows QLO Capital to focus on investment growth and performance. This structure brings together leading specialists that can fully exploit the growth prospects of the alliance."

press release, 8 Oct.13

***

In response to the need for a solution for early stage hedge fund managers to regain market share lost in recent years to the hedge fund giants, London based Trium Capital, is pleased to announce the launch of the Trium Multi-manager Alliance (“TMA”), an innovative alliance of early stage hedge fund managers.

TMA provides a solution both to managers needing a quality operational and distribution partner and to investors seeking emerging hedge fund talent with an experienced team providing operational support and risk oversight.

The alliance has been formed as a response to the increasing numbers of prospective hedge fund managers who are seeking to launch a hedge fund or are in the early stages of managing a fund, but for whom the operational and regulatory hurdles are too high in the early growth phase of their business. The alliance aims to stay relevant to managers throughout their growth cycle as the regulatory, due diligence and distribution landscape continues to shift.

Gareth James, CEO of Trium Capital, said “Investors need to be able to get exposure to the higher performing, more focused and less correlated early stage hedge fund managers without also taking the high business risk that this collective group present. TMA is designed to do this, we are facilitating the resurgence of early stage hedge fund managers.”

Press release, 8 Oct.13

trium-capital.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its